InvestorsHub Logo
Followers 11
Posts 264
Boards Moderated 0
Alias Born 08/25/2019

Re: None

Sunday, 02/16/2020 8:10:45 PM

Sunday, February 16, 2020 8:10:45 PM

Post# of 54913
Reality check:

We know there is a tremendous demand for tests and treatments in the female healthcare industry worldwide, and we know major pharmaceutical companies like Merck and Pfizer, and others, are getting out of the space.

We also know that PRED is targeting this same space, and through beta testing, we know the Artguide test is effective, and does what it promises.

Management has been clever enough to take care of finances w/the stem cell piece, as they continue working towards the predictive side of the company. Some may point to the falling stock price and two down quarters. It still doesn’t change the fact that PRED is making it work financially under their own steam, while they continue to grow the company with additional joint ventures.

Go review all of the acquisitions and mergers tied to PRED. Not a single company mentioned in these PRs has refuted PRED’s claims. Not one.

Go look at the early histories of pretty much any company that has made it big. Do you think their stock price had a straight linear graph trajectory to success? Do you think they had nothing but stellar quarterly financial reports in the beginning? Of course not. Give me a break.

We all know this intellectually, and yet somehow some of us forget these very important details when we see a stock price falling, and we let our emotions take over.

Be smarter than that.